Twitter's current travails with advertisers, with many of them hitting the pause button on advertising, has brought into focus the issue of brand safety. A recent study by Gurugram-based mFilterit, a company that works with advertisers on improving brand safety, says that at least 20-25 per cent of the digital advertising budget of a company is wasted because ads are sitting in brand-unsuitable environments.
Twitter, for instance, has had to deal with multiple advertiser calls for safety in the past, too.
A month ago, global advertisers such as Coca-Cola, Walt Disney and Mazda had to temporarily suspend advertising on Twitter after their ads were spotted next to offensive content.
In the current round, big spenders such as Mondelez, Pfizer, the Volkswagen group, General Mills and General Motors have hit the pause button. Ad and media agencies are also advising their clients to go slow with advertising on the platform.
Experts say that Twitter is not the only channel having to contend with brand unsafety in advertising. Google and Facebook, which are bigger digital advertising platforms in India, face similar issues.
The problem has become even more acute now, with uncertainty prevailing in the tech world. The content curation teams, for instance, were amongst those that were given pink slips in India as well as internationally at Twitter last week.
Bu hikaye Business Standard dergisinin November 10, 2022 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Business Standard dergisinin November 10, 2022 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
CDSCO cracks whip on drug units
Shuts down 36% of the 400-odd drug manufacturing facilities for failing to meet quality standards
USFDA flags drug quality concerns in India
The Center for Drug Evaluation and Research (CDER), a division of the US Food and Drug Administration (FDA), has expressed concern over the quality of drugs manufactured in India, asserting that it found violations at 11 per cent of the facilities it inspected in the country, the highest in any other global region, a senior official said.
Arundhati Roy gets UK's Pen Pinter Prize
Booker Prize-winning author Arundhati Roy, currently facing the threat of prosecution over historic comments on Kashmir 14 years ago, was on Thursday honoured with the prestigious Pen Pinter Prize 2024 for her \"unflinching and unswerving\" writings.
7 YEARS OF GST: MONTHLY COLLECTIONS SURGE 87%
With enhanced revenues, the stage seems set for GST 2.0
Launches may offer shot in arm for GSK Pharma
The stock of GlaxoSmithKline Pharmaceuticals, or GSK Pharma, has risen over 5 per cent in a week.
700% surge in 6 mths: 25 SME stocks reach for the sky
Stocks of small and medium enterprises (SME) have had a good run at the bourses, with select counters surging more than 700 per cent in calendar year 2024, according to data from ACE Equity.
Allied Blenders' IPO subscribed 23.5 times
Allied Blenders & Distillers's initial public offering (IPO) was subscribed 23.5 times on Thursday, the concluding day of the issue.
'Tax relief will be big positive for markets'
All eyes are on Union Budget proposals that will in July show the policy intent of the new government.
Fairfax group divests 9.7% stake in CSB Bank
Canadian billionaire Prem Watsa's Fairfax group on Thursday divested a 9.7 per cent stake in CSB Bank through its arm FIH Mauritius Investments.
Dr Reddy's in pink of health after Haleon's NRT biz acquisition
Dr Reddy's Laboratories (DRL) is set to acquire Haleon's global portfolio of consumer healthcare brands in the nicotine replacement therapy (NRT) category outside of the US.
